Adipose-Specific Lipin-1 Overexpression Renders Hepatic Ferroptosis and Exacerbates Alcoholic Steatohepatitis in Mice
Overview
Affiliations
Lipin-1 is a Mg-dependent phosphatidic acid phosphohydrolase involved in the generation of diacylglycerol during synthesis of phospholipids and triglycerides. Ethanol-mediated inhibitory effects on adipose-specific lipin-1 expression were associated with experimental steatohepatitis in rodents. In the present study, using an adipose-specific lipin-1 overexpression transgenic (-Tg) mouse model, we tested a hypothesis that adipose-specific lipin-1 overexpression in mice might dampen ethanol-induced liver damage. Experimental alcoholic steatohepatitis was induced by pair-feeding ethanol to -Tg and wild-type (WT) mice using the chronic-plus-binge ethanol feeding protocol. Unexpectedly, following the chronic-plus-binge ethanol challenge, -Tg mice exhibited much more pronounced steatosis, exacerbated inflammation, augmented elevation of serum liver enzymes, hepatobiliary damage, and fibrogenic responses compared with the WT mice. Mechanistically, overexpression of adipose lipin-1 in mice facilitated the onset of hepatic ferroptosis, which is an iron-dependent form of cell death, and subsequently induced ferroptotic liver damage in mice under ethanol exposure. Concurrently, adipose lipin-1 overexpression induced defective adiponectin signaling pathways in ethanol-fed mice. : We identified ferroptosis as a mechanism in mediating the detrimental effects of adipose-specific lipin-1 overexpression in mice under chronic-plus-binge ethanol exposure. Our present study sheds light on potential therapeutic approaches for the prevention and treatment of human alcoholic steatohepatitis.
From mechanisms to medicine: Ferroptosis as a Therapeutic target in liver disorders.
He Y, Lin Y, Song J, Song M, Nie X, Sun H Cell Commun Signal. 2025; 23(1):125.
PMID: 40055721 PMC: 11889974. DOI: 10.1186/s12964-025-02121-2.
Selenomethionine Alleviates Alcohol-Induced Liver Injury by Inhibiting Ferroptosis.
Chen F, Zhou Z, Fu J, Gao C Dig Dis Sci. 2025; .
PMID: 40029572 DOI: 10.1007/s10620-025-08960-w.
Ferroptosis: mechanism and role in diabetes-related cardiovascular diseases.
Wang Z, Wu C, Yin D, Dou K Cardiovasc Diabetol. 2025; 24(1):60.
PMID: 39920799 PMC: 11806630. DOI: 10.1186/s12933-025-02614-x.
[Ferroptosis and liver diseases].
Li X, Tao L, Zhong M, Wu Q, Min J, Wang F Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025; 53(6):747-755.
PMID: 39757742 PMC: 11736349. DOI: 10.3724/zdxbyxb-2024-0566.
Ferroptosis and its impact on common diseases.
Zou P, He Q, Xia H, Zhong W PeerJ. 2024; 12:e18708.
PMID: 39713140 PMC: 11663406. DOI: 10.7717/peerj.18708.